Names and Addresses of Representatives. The Union will inform the Company in writing as to the names and addresses of its officers, negotiating committee members, shop stewards and any other persons who are authorized representatives of the Union in matters which are appropriate under the provisions of this agreement. The Union will also inform the Company in writing of any changes to such list of names.
Names and Addresses of Representatives. The Union shall inform the City in writing as to the names and addresses of its officers, negotiating committee members, shop stewards and any other persons who are authorized representatives of the Union in matters which are appropriate under the provisions of this Agreement. The Union shall also inform the City in writing of any changes to such list of names.
5.05.01 The City shall provide the Union with a list of employee names, telephone numbers and addresses in June and December each year or as mutually agreed by both parties. This information is provided with the mutual understanding that the Union will use such personal information for the express purpose of the administration of the union and carrying out the Union’s responsibilities as the exclusive agent of employees covered by this Agreement relative to their members’ employment relationship with the City of Edmonton. The Union shall take all reasonable steps to store and manage this information to
Names and Addresses of Representatives. The Union shall inform the Foundation in writing as to the names and addresses of its officers, negotiating committee members, shop stewards and any other persons who are authorized representatives of the Union in matters which are appropriate under the provisions of this Agreement. The Union shall also inform the Foundation in writing of any changes to such list of names.
Names and Addresses of Representatives. As to the 20 Notes (and designated to act on behalf of the other Underwriters or other Representatives):
Names and Addresses of Representatives. Citigroup Global Markets Inc. 300 Xxxxxxxxx Xxxxxx Xxx Xxxx, XX 00000 Attention: General Counsel (Fax: 200-000-0000) J.X. Xxxxxx Securities Inc. 200 Xxxx Xxxxxx Xxx Xxxx, XX 00000 Attention: Investment Grade Syndicate Desk (Fax: 200-000-0000) The Underwriters have furnished to the Company for use in the Prospectus Supplement:
Names and Addresses of Representatives. As to the 2027 Notes and the 2047 Notes (and designated to act on behalf of the other Underwriters or other Representatives): X.X. Xxxxxx Securities LLC 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Investment Grade Syndicate Desk Fax No.: (000) 000-0000 Xxxxxxx, Xxxxx & Co. 000 Xxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000-0000 Attention: Registration Department Facsimile: (000) 000-0000 Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 00 Xxxxxxxxxxx Xxxxx, XX0-000-00-00 Xxx Xxxx, Xxx Xxxx 00000 Attention: High Grade Debt Capital Markets Transaction Management/Legal Fax No.: (000) 000-0000 Xxxxxx Xxxxxxx & Co. LLC 0000 Xxxxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Investment Banking Division Facsimile: (000) 000-0000 • Final term sheet, dated March 8, 2017, relating to the 2027 Notes and the 2047 Notes, as filed pursuant to Rule 433 under the Securities Act. Issuer: UnitedHealth Group Incorporated Ratings (Xxxxx’x / S&P / Fitch)*: [Intentionally Omitted] Note Type: SEC Registered (No. 333-216150) Trade Date: Xxxxx 0, 0000 Xxxxxxxxxx Date (T+3): Xxxxx 00, 0000 Xxxxxxxx Date: April 15, 2027 (the “2027 Notes”) April 15, 2047 (the “2047 Notes”) Principal Amount Offered: $625,000,000 (2027 Notes) $725,000,000 (2047 Notes) Price to Public (Issue Price): 99.489% (2027 Notes) 99.810% (2047 Notes) Net Proceeds (Before Expenses) to Issuer: $618,993,750 (99.039%) (2027 Notes) $718,185,000 (99.060%) (2047 Notes) Interest Rate: 3.375% (2027 Notes) 4.250% (2047 Notes) Interest Payment Dates: April 15 and October 15, commencing October 15, 2017 (2027 Notes) April 15 and October 15, commencing October 15, 2017 (2047 Notes)
Names and Addresses of Representatives. As to the 2024 Notes, the 2029 Notes, the 2039 Notes, the 2049 Notes and the 2059 Notes (and designated to act on behalf of the other Underwriters or other Representatives): BofA Securities, Inc. 00 Xxxxxxxxxxx Xxxxx, XX0-000-00-00 Xxx Xxxx, Xxx Xxxx 00000 Facsimile: (000) 000-0000 Attention: High Grade Debt Capital Markets Transaction Management/Legal Barclays Capital Inc. 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Syndicate Registration Facsimile: (000) 000-0000 Citigroup Global Markets Inc. 000 Xxxxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: General Counsel Facsimile: (000) 000-0000 U.S. Bancorp Investments, Inc. 000 Xxxxx Xxxxx Xxxxxx, 26th Floor Charlotte, North Carolina 28202 Attention: Debt Capital Markets Facsimile: (000) 000-0000 Xxxxx Fargo Securities, LLC 000 Xxxxx Xxxxx Xxxxxx, 5th Floor Charlotte, North Carolina 28202 Attention: Transaction Management • Final term sheet, dated July 23, 2019, relating to the 2024 Notes, the 2029 Notes, the 2039 Notes, the 2049 Notes and the 2059 Notes, as filed pursuant to Rule 433 under the Securities Act. Issuer: UnitedHealth Group Incorporated Ratings (Xxxxx’x / S&P / Fitch)*: [Intentionally omitted] Note Type: SEC Registered (No. 333-216150) Trade Date: July 23, 2019 Settlement Date (T+2): July 25, 2019 Maturity Date: August 15, 2024 (the “2024 Notes”) August 15, 2029 (the “2029 Notes”) August 15, 2039 (the “2039 Notes”) August 15, 2049 (the “2049 Notes”) August 15, 2059 (the “2059 Notes”) Principal Amount Offered: $750,000,000 (2024 Notes) $1,000,000,000 (2029 Notes) $1,250,000,000 (2039 Notes) $1,250,000,000 (2049 Notes) $1,250,000,000 (2059 Notes) Price to Public (Issue Price): 99.975% (2024 Notes) 99.973% (2029 Notes) 99.016% (2039 Notes) 99.656% (2049 Notes) 99.112% (2059 Notes) Net Proceeds (Before Expenses) to Issuer: $747,187,500 (99.625%) (2024 Notes) $995,230,000 (99.523%) (2029 Notes) $1,229,575,000 (98.366%) (2039 Notes) $1,236,325,000 (98.906%) (2049 Notes) $1,228,900,000 (98.312%) (2059 Notes) Interest Rate: 2.375% (2024 Notes) 2.875% (2029 Notes) 3.500% (2039 Notes) 3.700% (2049 Notes) 3.875% (2059 Notes) Interest Payment Dates: February 15 and August 15, commencing February 15, 2020 (2024 Notes) February 15 and August 15, commencing February 15, 2020 (2029 Notes) February 15 and August 15, commencing February 15, 2020 (2039 Notes) February 15 and August 15, commencing February 15, 2020 (2049 Notes) February 15 and August 15, commencing February 15, 2020 (2059 Notes) Regular ...
Names and Addresses of Representatives. Designated Representatives: Xxxxxxx, Xxxxx & Co. Address for Notices, etc.: 00 Xxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Pursuant to Section 7(e) of the Underwriting Agreement, the accountants shall furnish letters to the Underwriters to the effect that:
Names and Addresses of Representatives. As to the 2017 Notes, the 2019 Notes and the 2021 Notes (and designated to act on behalf of the other Underwriters or other Representatives): Xxxxxxx, Sachs & Co. 000 Xxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Prospectus Department
Names and Addresses of Representatives. The respective principal amounts of the Debt Securities to be purchased by each of the Underwriters are set forth opposite their names in Schedule A hereto. The provisions of the Underwriting Agreement are incorporated herein by reference. The Closing will take place at___ A.M., New York City time, on ___________ , 199__, at the offices of ___________________________________ . The Securities will be made available for checking and packaging at the office of not later than 2:00 p.m., New York City time, on the business day prior to the Delivery Date. Please signify your acceptance by signing the enclosed response to us in the space provided and returning it to us. Very truly yours, SCHEDULE A DEBT SECURITIES UNDERWRITER PRINCIPAL AMOUNT __________ Total __________
